These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503 [TBL] [Abstract][Full Text] [Related]
3. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460 [TBL] [Abstract][Full Text] [Related]
5. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light]. Harth Y; Hirshovitz B Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421 [TBL] [Abstract][Full Text] [Related]
6. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up. Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580 [TBL] [Abstract][Full Text] [Related]
9. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Stables GI; Stringer MR; Robinson DJ; Ash DV Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease. Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB; Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399 [TBL] [Abstract][Full Text] [Related]
12. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? Morton CA J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514 [TBL] [Abstract][Full Text] [Related]
14. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973 [TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light. Yu CH; Lin HP; Chen HM; Yang H; Wang YP; Chiang CP Lasers Surg Med; 2009 Nov; 41(9):628-33. PubMed ID: 19816916 [TBL] [Abstract][Full Text] [Related]
16. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study. Christensen E; Mørk C; Skogvoll E Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease. Mizutani K; Akita Y; Yanagishita T; Kimura M; Tanaka T; Kinoshita Y; Nakano A; Tamada Y; Matsumoto Y; Watanabe D Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):142-6. PubMed ID: 22548396 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study. Kacerovská D; Pizinger K; Majer F; Smíd F Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625 [TBL] [Abstract][Full Text] [Related]
19. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010 [TBL] [Abstract][Full Text] [Related]
20. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]